30th Oct 2019 08:23
(Alliance News) - Dechra Pharmaceuticals PLC said Wednesday it has appointed acting Chief Financial Officer Paul Sandland as executive director and permanent CFO with immediate effect.
The veterinary pharmaceuticals firm said Sandland, who is a chartered certified accountant, was group's acting CFO between 2012-2013 prior to becoming veterinary products EU finance director.
Tony Rice, chairman, said: "Paul has proven to be an excellent acting CFO and, over a much longer period, has clearly demonstrated a strong practical understanding of all parts of the group and its needs, as well as an independence of mind and strong technical, strategic and commercial skills."
"The company followed a rigorous process before appointing Paul. He has been a core part of the Dechra leadership team over the last ten years," Rice said.
Dechra Pharmaceuticals shares were down 0.1% in London at 2,590.00 pence each on Wednesday morning.
By Loreta Juodagalvyte; [email protected]
Copyright 2019 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L